By the New York Times
Expecting to gain seats in Congress, Democrats are drafting an ambitious healthcare agenda to carry out their campaign promises with legislation to lower drug costs for older Americans, provide more money for children's health insurance and expand research using embryonic stem cells. Many Democrats in the House and the Senate say they want federal officials to negotiate directly with pharmaceutical companies to obtain lower prices for Medicare beneficiaries. The 2003 Medicare law explicitly prohibits such negotiations.
Read the full Times story.